- Dr. Benjamin Ascher, a Leading French Plastic Surgeon, Will Present his UltraShape Clinical Results at the International Society of Aesthetic
Plastic Surgery Meeting in Melbourne, AU From Feb. 10-13
YOQNEAM, Israel and SAN RAMON, Calif., Feb. 10 /PRNewswire/ -- Renowned French Plastic Surgeon, Dr. Benjamin Ascher will present his latest findings from clinical experience with UltraShape(TM) Contour I at the 19th annual International Society of Aesthetic Plastic Surgery (ISAPS) meeting to be held in Melbourne, Australia from February 10-13. UltraShape is the clinically proven non-invasive solution for fat reduction and body contouring using "non- thermal" selective focused ultrasound technology.
Dr. Benjamin Ascher of the Clinique of Aesthetic Surgery IENA in Paris, France, and Course Director the IMCAS Congresses (International Master Course on Aging Skin and Aesthetic Surgery), will present his two most recent clinical trials. The first clinical trial (carried out from January through October 2006) involved 130 patients. Results demonstrated that following a three-treatment protocol using the UltraShape Contour I system, 92% of patients experienced a measurable reduction in body circumference and 88% of patients expressed satisfaction with their results. The second trial (conducted from October 2006 through January 2007 on 24 patients) follows a three-treatment protocol, with shortened intervals between treatments, and has demonstrated preliminary results of successful mean circumferential reduction of 3.54 cm after only two treatments. Dr. Ascher commented, "My patients have been extremely satisfied with the pain-free, 'walk-in, walk out' nature of UltraShape procedure and the long-lasting fat reduction and body contouring effects. As an Aesthetic Surgeon, I am pleased both with the results my patients have experienced from UltraShape's innovative technology and the role that it has played as a growth engine for my clinic."
As part of the ISAPS on-going efforts to provide physicians with the latest information and access to innovative procedures, Robert Gerberich, President of UltraShape Americas & APAC will review the UltraShape technology and the extensive scientific research and published clinical studies supporting its' safety and efficacy, and Ido Frank, UltraShape's Clinical Applications Specialist, will provide a live demonstration and hands-on workshop.
Rodger Stewart, UltraShape President and CEO stated, "UltraShape is honored to contribute to the ISAPS initiative of uniting physicians with the latest and most innovative technology in medical aesthetics. The positive results of the independent study, by such a renowned plastic surgeon as Dr. Benjamin Ascher, confirm UltraShape's safety and effectiveness. Physicians working with UltraShape around the world have seen positive results in their patients and a successful impact on their clinics."
The International Society of Aesthetic Plastic Surgery (ISAPS) is the world's leading professional body for board certified aesthetic plastic surgeons. The Society was founded to provide a forum for, "The interchange of ideas and knowledge for the advancement of aesthetic plastic surgery." In addition, ISAPS has become the gold standard for providing continuing education to its members in new procedures, techniques and options in aesthetic and reconstructive plastic surgery.
ISAPS membership is drawn from over 1,300 of the world's best known and respected reconstructive and aesthetic plastic surgeons in 73 countries on every continent. Reflecting the true international mission of the organization, ISAPS' charter was signed at the United Nations. For more information, please visit http://www.isaps.org
About the UltraShape CONTOUR I
The UltraShape Contour I system, based on patented focused ultrasound technology, is the first scientifically and clinically proven non-invasive fat reduction and body contouring solution for both men and women. The device produces mechanical, non-thermal, acoustic effects which targets and selectively destroys fat cells, leaving surrounding critical structures such as skin, blood vessels, nerves, and connective tissue intact. The UltraShape procedure is guided by proprietary real-time tracking and guidance technology designed to deliver smooth, uniform body contouring results. The software guarantees adherence to a pre-determined treatment algorithm minimizing risk of contour irregularities, a common side effect of liposuction. The UltraShape procedure is performed during a convenient, "walk-in, walk-out" session carried out in an office-based environment; it requires no anesthesia or sedation, and the vast majority of patients report no pain or discomfort. After treatment, patients immediately resume their daily routines with no need for maintenance treatments. The UltraShape procedure is available in 50 countries and over 50,000 patient treatments have been performed worldwide with high patient satisfaction. The UltraShape Contour I received the CE Mark in 2005 and a medical device license from Health Canada in 2007. The UltraShape Contour I system is not available for sale in the United States.
UltraShape is redefining aesthetic medicine by developing,
manufacturing and marketing innovative non-invasive technologies for body
contouring. The company is dedicated to providing clinically proven safe
and effective solutions that enhance the lives of patients worldwide. The
UltraShape proprietary non-invasive body contouring technology is based on
focused ultrasound that targets and selectively disrupts fat cells without
affecting surrounding structures. Founded in 2000, UltraShape is a
privately held and venture backed company. For more information visit
Gitam Porter Novelli
|SOURCE UltraShape Ltd.|
Copyright©2008 PR Newswire.
All rights reserved